Weather , , 0°C

Small Cell Lung Cancer (SCLC) Market Analysis, Market Size, Trends, Epidemiology, Leading Companies And Therapies | DelveInsight

 Breaking News
  • No posts were found

Small Cell Lung Cancer (SCLC) Market Analysis, Market Size, Trends, Epidemiology, Leading Companies And Therapies | DelveInsight

May 26
20:50 2021
Small Cell Lung Cancer (SCLC) Market Analysis, Market Size, Trends, Epidemiology, Leading Companies And Therapies | DelveInsight

DelveInsight Business Research LLP
DelveInsight’s “Small Cell Lung Cancer (SCLC) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Small Cell Lung Cancer (SCLC), historical and forecasted epidemiology as well as the Small Cell Lung Cancer (SCLC) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on “Small Cell Lung Cancer (SCLC) -Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’s “Small Cell Lung Cancer (SCLC)  – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Small Cell Lung Cancer (SCLC) , historical and forecasted epidemiology as well as the  Small Cell Lung Cancer (SCLC)  market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Report:

  1. Total incident cases of SCLC in the 7MM was assessed to be 85,540 in 2017, and are expected to increase during the study period. 

  2. Among the European 5 countries, Germany had the highest incident population of SCLC, followed by the United Kingdom and France. On the other hand, Spain had the lowest incident cases of SCLC in 2017. Furthermore, Japan accounts for 21% of the 7MM patient population of SCLC.

  3. In 2017, a greater number of males were affected by the disease, i.e., 55% of the SCLC cases in the 7MM, in comparison to the females. However, the incidence gap between males and females has narrowed over the past three decades.

Key benefits of the report:

1. Small Cell Lung Cancer (SCLC) market report covers a descriptive overview and comprehensive insight of the Small Cell Lung Cancer (SCLC)  epidemiology and Small Cell Lung Cancer (SCLC) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2. The Small Cell Lung Cancer (SCLC) market report provides insights on the current and emerging therapies.

3. Small Cell Lung Cancer (SCLC) market report provides a global historical and forecasted market covering drug outreach in 7MM.

4. The Small Cell Lung Cancer (SCLC) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Small Cell Lung Cancer (SCLC) market.

Request for sample pages: https://www.delveinsight.com/report-store/small-cell-lung-cancer-market

Small Cell Lung Cancer (SCLC): Overview

The two major types of lung cancer are small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).SCLC accounts for about 13 percent of all lung cancers. It’s less common than NSCLC, according to the American Cancer Society (ACS).

However, SCLC is the more aggressive form of lung cancer. With SCLC, the cancer cells tend to grow quickly and travel to other parts of the body, or metastasize, more easily.As a result, the condition is usually only diagnosed after the cancer has spread throughout the body, making recovery less likely. If SCLC is detected early, however, it may be treated effectively before the cancer advances.

SCLC may also be referred to as:

  • oat cell cancer

  • oat cell carcinoma

  • small cell undifferentiated carcinoma

The key players involved in the Small Cell Lung Cancer (SCLC) market:

  1. Astrazeneca

  2. G1 Therapeutics

  3. United Therapeutics 

  4. EpicentRx

  5. PharmaMar

The launch of the emerging therapies is expected to significantly impact the  Small Cell Lung Cancer (SCLC)  treatment scenario in the upcoming years:-

Drug covered

  1. Imfinzi

  2. Trilaciclib (G1T28)

  3. Dinutuximab

  4. RRx-001

  5. Lurbinectedin

Request a free sample report @https://www.delveinsight.com/report-store/small-cell-lung-cancer-market

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Small Cell Lung Cancer (SCLC) Patient Share (%) Overview at a Glance

5. Small Cell Lung Cancer (SCLC) Market Overview at a Glance

6. Small Cell Lung Cancer (SCLC) Disease Background and Overview

7. Small Cell Lung Cancer (SCLC) Epidemiology and Patient Population

8. Country-Specific Patient Population of Small Cell Lung Cancer (SCLC) 

9. Small Cell Lung Cancer (SCLC) Current Treatment and Medical Practices

10. Unmet Needs

11. Small Cell Lung Cancer (SCLC) Emerging Therapies

12. Small Cell Lung Cancer (SCLC) Market Outlook

13. Country-Wise Small Cell Lung Cancer (SCLC) Market Analysis (2017–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Small Cell Lung Cancer (SCLC) Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Related Reports:

Small Cell Lung Cancer (SCLC)- Pipeline Insights, 2021

“Small Cell Lung Cancer (SCLC)- Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Small Cell Lung Cancer (SCLC) market. A detailed picture of the Small Cell Lung Cancer (SCLC) pipeline landscape is provided, which includes the disease overview and Small Cell Lung Cancer (SCLC) treatment guidelines.

Small Cell Lung Cancer (SCLC) -Epidemiology Forecast to 2030

DelveInsight’s ‘Small Cell Lung Cancer (SCLC) – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Small Cell Lung Cancer (SCLC){;l epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Related Articles

Calendar

September 2021
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  

Categories